BioWorld MedTech

July 14, 2011

Deals roundup: Private consortium set to pay $6.3 billion for Kinetic Concepts

A group of private equity investors have officially offered to buy Kinetic Concepts (KCI; San Antonio) for $68.50 a share in a cash deal valued at $6.3 billion (including KCI's outstanding debt). (Medical Device Daily) Read More

St. Jude Medical receives FDA approval for Epiducer

International report: EarlySense monitoring system now cleared for sale in Canada

Washington roundup: Foster; 'little incentive for cost-reducing technology'

Financings roundup: InSite to take part in private placement for $22.2 million

MDD's food for med-tech thought

People in the News

HIT roundup: Sermo launches new mobile application for physicians

Court Report: Acacia subsidiary settles with Boston Sci in patent dispute

Med-Tech Notes

Patent watch: Molecular Detection receives notice for antibiotic bacteria

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for April 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 15, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Antibodies binding to spike proteins on the surface of SARS-CoV-2 virus

Australian researchers discover new compound to treat long COVID

BioWorld

Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....

Blood glucose chart and monitor, stethoscope, injector pen

Hightide’s HTD-1801 meets phase III endpoints in type 2 diabetes

BioWorld

Hightide Therapeutics Inc.’s berberine ursodeoxycholate (HTD-1801) met primary and secondary endpoints in the Symphony 1 and Symphony 2 phase III trials in type 2...